All lobbying filings
DH DIAGNOSTICS LLC
Lobbying for DH DIAGNOSTICS, LLC · Diagnostics manufacturers
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Expenses
$220,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
California
Lobbyists on this filing
1
-
PAUL ORDAL New on this filingPreviously held: Special Assistant, U.S. Senate Committee on Environment and Public Works 2007-2015; Legislative Assistant/Director of Special Projects, U.S. Senator Barbara Boxer 2015-2017.
Government bodies contacted
6
Lobbying activity
4
Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act
Funding for diagnostics
Medical device supply-chain resilience, including semiconductor and memory-chip availability.
Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352/S.4875, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025